HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Description

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.

Conditions

Heart Failure

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.

Hemodynamic Frontiers in Heart Failure Registry

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

La Jolla

Scripps Health, La Jolla, California, United States, 92037

Bloomington

Indiana University, Bloomington, Indiana, United States, 47401

Kansas City

University of Kansas Medical Center, Kansas City, Kansas, United States, 66160

Maplewood

Fairview Health, Maplewood, Minnesota, United States, 55109

Minneapolis

Minneapolis Heart Institute Foundation/ Allina Health, Minneapolis, Minnesota, United States, 55407

Kansas City

Saint Luke's Health System, Kansas City, Missouri, United States, 64131

Raleigh

University of North Carolina/ Rex Hospital, Inc., Raleigh, North Carolina, United States, 27607

Portland

Providence Heart Institute, Portland, Oregon, United States, 97225

Columbia

Prisma Health, Columbia, South Carolina, United States, 29203

Sioux Falls

Sanford Health, Sioux Falls, South Dakota, United States, 57104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. All patients would have been or will be implanted per indications from FDA approval/CHAMPION trial. These would be patients with NYHA (New York Heart Association) Class III heart failure who had a prior hospitalization.
  • 2. Patients who meet the expanded FDA indication (BNP elevation without hospitalization or NYHA class II).
  • 1. Patients less than 18 years of age.
  • 2. Pregnant women at the scheduled time of PA pressure sensor implant.
  • 3. Patients unable or unwilling to have continuity of care in the heart failure clinic.

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

Hirak Shah, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

2030-12-31